Author Details

Ryazhenov, V V, I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation; Center for Strategic Researches in Health Care "Quality medical Technology"

Issue Section Title File
Vol 19, No 1 (2017) Articles The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies